Poll: Some U.K. doctors silent about new cancer drugs

Some British myeloma specialists are holding back information about costly new treatments that may be difficult to obtain through the National Health Service to avoid distressing patients, according to a poll from Myeloma UK. The charity's survey came after the National Institute for Health and Clinical Excellence deemed four kidney cancer treatments too expensive for NHS use.

View Full Article in:

Times (London) (subscription required), The · Telegraph (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA